Hematopoietic Stem Cell Transplantation Market Poised to Witness High Growth Due to Advancements in Gene Editing Technol

Comments · 106 Views

3D bioprinting of tissues and organs, development of universal donor cells are expected to drive the HSCT market.

With advancements in gene-editing technologies like CRISPR revolutionizing cell therapies, the hematopoietic stem cell transplantation (HSCT) market is estimated to witness high growth. HSCT involves transplanting hematopoietic stem cells (HSCs) from blood, bone marrow, or umbilical cord blood to treat conditions like blood cancers, bone marrow disorders, and genetic disorders. HSCT helps restore the patient's bone marrow and immune system. The HSCT procedure is used as a treatment option for various diseases like leukemia, lymphoma, myeloma, sickle cell anemia, and thalassemia. With the growing prevalence of such conditions worldwide, the need for HSCT is increasing.

The Global HSCT Market is estimated to be valued at US$ 3.57 Billion in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the HSCT market are Pluristem Therapeutics Inc., CellGenix GmbH, Regen Biopharma Inc., Lonza Group, Kiadis Pharma, Taiga Biotechnologies, Inc., Takeda Pharmaceutical Company Limited, Escape Therapeutics, Inc., Bluebird Bio, Inc., Talaris Therapeutics, Inc., Marker Therapeutics Inc., Stempeutics Research Pvt Ltd., CBR Systems Inc., Priothera Ltd., Eurobio Scientific Group, Otsuka America Pharmaceutical, Inc., Pfizer Inc., Sanofi, FUJIFILM Holdings Corporation. The key opportunities in the market include a large patient pool suffering from target diseases, ongoing research on stem cell therapies, and growing awareness about HSCT. Technological advancements like gene editing, 3D bioprinting of tissues and organs, development of universal donor cells are expected to drive the HSCT market.

Market Drivers

One of the key drivers for the Hematopoietic Stem Cell Transplantation Market Size is the rising prevalence of target diseases like blood cancers, genetic disorders, and bone marrow failures globally. According to statistics, around 300,000+ hematopoietic stem cell transplants are performed annually worldwide. Another major driver is the continued research on stem cell therapies for various conditions. Advancements in gene editing technologies are also supporting the development of novel cell therapy products.

Get More Insights on- Hematopoietic Stem Cell Transplantation Market

For Deeper Insights, Find the Report in the Language that You want:

 

Comments